Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that three shots of
Moderna Inc (NASDAQ: MRNA) joins hands with the Botswana government to supply vaccine doses through the GAVI-led COVAX vaccine sharing scheme. The Modern said that the
Death, Taxes, and Covid shots. The future stretching out in front of us has maybe only these three certainties. The virus is actively mutating constantly,
American Airlines Group Inc (NASDAQ:AAL) is currently flying about 55% of its seat capacity, a phenomenon analysts describe as a bullish performance. The airline disclosed
Pfizer (NYSE:PFE) has indicated that it will continue supplying its COVID-19 vaccine to Italy as per the European Commission agreement even as the government considers
The re-opening narrative is dominating activity in the market and governs decisions being made in the business economy, and with good reason. Perhaps never before
Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in
Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates
The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years.
Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of
A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the
Eventually, there will be a vaccine. But, according to the WHO leadership even yesterday, confidence is waning in a “silver bullet” pharma solution for COVID-19.
Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock
Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that three shots of
Moderna Inc (NASDAQ: MRNA) joins hands with the Botswana government to supply vaccine doses through the GAVI-led COVAX vaccine sharing scheme. The Modern said that the
Death, Taxes, and Covid shots. The future stretching out in front of us has maybe only these three certainties. The virus is actively mutating constantly,
American Airlines Group Inc (NASDAQ:AAL) is currently flying about 55% of its seat capacity, a phenomenon analysts describe as a bullish performance. The airline disclosed
Pfizer (NYSE:PFE) has indicated that it will continue supplying its COVID-19 vaccine to Italy as per the European Commission agreement even as the government considers
The re-opening narrative is dominating activity in the market and governs decisions being made in the business economy, and with good reason. Perhaps never before
Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in
Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates
The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years.
Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of
A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the
Eventually, there will be a vaccine. But, according to the WHO leadership even yesterday, confidence is waning in a “silver bullet” pharma solution for COVID-19.
Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock
